SES - Delayed Quote SGD
Haw Par Corporation Limited (H02.SI)
13.00
+0.04
+(0.31%)
At close: May 2 at 5:04:51 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
239,059
244,824
232,062
182,092
141,180
Cost of Revenue
102,663
110,737
97,174
83,526
67,538
Gross Profit
136,396
134,087
134,888
98,566
73,642
Operating Expense
68,988
70,245
70,877
55,187
48,945
Operating Income
67,408
63,842
64,011
43,379
24,697
Net Non Operating Interest Income Expense
1,366
27,580
23,962
-525
-27
Pretax Income
247,408
246,118
229,394
158,969
116,180
Tax Provision
12,980
17,844
12,825
10,653
6,077
Net Income Common Stockholders
234,428
228,274
216,569
148,316
110,103
Diluted NI Available to Com Stockholders
234,428
228,274
216,569
148,316
110,103
Basic EPS
1.03
--
0.98
0.67
0.50
Diluted EPS
1.03
--
0.98
0.67
0.50
Basic Average Shares
221,410.28
--
221,440.70
221,368
221,273
Diluted Average Shares
221,410.28
--
221,440.70
221,368
221,293
Total Expenses
171,651
180,982
168,051
138,713
116,483
Net Income from Continuing & Discontinued Operation
234,428
228,274
216,569
148,316
110,103
Normalized Income
234,428
228,274
216,569
148,316
110,103
Interest Income
--
29,665
25,517
7,779
--
Interest Expense
1,902
2,085
1,555
525
27
Net Interest Income
1,366
27,580
23,962
-525
-27
EBIT
249,310
248,203
230,949
159,494
116,207
EBITDA
255,462
254,314
236,997
165,178
122,670
Reconciled Cost of Revenue
102,663
110,737
97,174
83,526
67,538
Reconciled Depreciation
6,152
6,111
6,048
5,684
6,463
Net Income from Continuing Operation Net Minority Interest
234,428
228,274
216,569
148,316
110,103
Normalized EBITDA
255,462
254,314
236,997
165,178
122,670
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NOTA.BE Novartis AG
99.60
+0.40%
NOVNEE.SW Novartis AG
94.36
+1.02%
NOTA.DU Novartis AG
100.50
+0.90%
1093.HK CSPC PHARMA
6.210
+1.31%
GRF.MC Grifols, S.A.
8.53
+2.82%
GRFS Grifols, S.A.
7.35
+4.70%
SAN.PA Sanofi
97.92
+2.11%
AZN.L AstraZeneca PLC
10,754.00
+1.38%
GSK GSK plc
39.07
+0.83%
BAYN.DE Bayer Aktiengesellschaft
23.88
+3.69%